BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2011
View Archived Issues
Interim phase I data on E-7080 in hepatocellular carcinoma disclosed at ILCA meeting
Read More
FDA advisory committee to review rivaroxaban NDA following ROCKET AF study
Read More
Bayer discloses preclinical data on dual vasopressin V1A/V2 receptor antagonist
Read More
Long-term therapy with cysteamine eye drops assessed in subjects with cystinosis
Read More
Aeterna Zentaris selective ERK-1/ERK-2 inhibitor shows anticancer activity in vivo
Read More
Novel biocrea phosphodiesterase 2 inhibitor has procognitive effects
Read More
High Point Pharmaceuticals claims new heme oxygenase 1 production inducers and/or activity enhancers
Read More
Transgene Biotek develops new recombinant therapeutic for liver cancer
Read More
GSK receives BARDA contract to develop boron-based antibiotic
Read More
New microRNA-based therapies disclosed by University of Miami
Read More
Novel SsIR-based vaccines created against nematode infection
Read More
Okayama University claims new iodobenzyl-bleomycin analogues
Read More
TWi Biotechnology completes enrollment in phase IIb AC-201 trial
Read More
Phase II MG-01CI trial meets primary endpoints
Read More
BHR Pharma advances phase III SyNAPSe trial
Read More
Topline phase IIIb data on Xiaflex in Dupuytren's contracture with multiple palpable cords
Read More
ImmunoCellular Therapeutics updates on phase II ICT-107 trial
Read More
FDA clears Fujirebio immunoassay for use in ROMA algorithm to determine ovarian cancer risk
Read More
Zytiga approved in Europe
Read More
Debiopharm and Ascenta Therapeutics announce exclusive license agreement for AT-406
Read More
Prespecified number of events reached for unblinding of Exelixis' EXAM trial
Read More
Verona Pharma's VRP-700 significantly reduces coughing in Italian study
Read More
Novartis gains E.U. approval for Votubia
Read More
Takeda advances DPP IV inhibitor into Japanese phase III trials in type 2 diabetes
Read More
FDA updates boxed warning for all TNF-alpha inhibitors
Read More